Nike Men’s Lunarsolo Gs Trail Running Shoes Grey Pure Platinum/Blackwolf Greydark Grey 002 aZQ9ji

B06XD1PRLM
Nike Men’s Lunarsolo (Gs) Trail Running Shoes Grey (Pure Platinum/Black-wolf Grey-dark Grey 002) aZQ9ji
  • Outer Material: Synthetic
  • Inner Material: Manmade
  • Sole: Synthetic
  • Closure: Lace-Up
Nike Men’s Lunarsolo (Gs) Trail Running Shoes Grey (Pure Platinum/Black-wolf Grey-dark Grey 002) aZQ9ji Nike Men’s Lunarsolo (Gs) Trail Running Shoes Grey (Pure Platinum/Black-wolf Grey-dark Grey 002) aZQ9ji Nike Men’s Lunarsolo (Gs) Trail Running Shoes Grey (Pure Platinum/Black-wolf Grey-dark Grey 002) aZQ9ji Nike Men’s Lunarsolo (Gs) Trail Running Shoes Grey (Pure Platinum/Black-wolf Grey-dark Grey 002) aZQ9ji
Follow us on web
Newsletter
Calendar
Language
Newsletter
Browse
Pharmaceuticals

Explore Other Industries

Indian pharmaceutical industry supplies over 50 per cent of global demand vaccines.

Latest update: June, 2018

Notes: Source:

Industry

Browse:

Related News

Last Updated: July 03, 2018

Last Updated: June, 2018

Introduction

India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK.

India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

Market Size

The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18 and are expected to reach US$ 20 billion by 2020.

Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).

Investments

The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 15.59 billion between April 2000 and December 2017, according to data released by the Department of Industrial Policy and Promotion (DIPP).

Some of the recent developments/investments in the Indian pharmaceutical sector are as follows:

Government Initiatives

Some of the initiatives taken by the government to promote the pharmaceutical sector in India are as follows:

Road Ahead

Medicine spending in India is expected to increase at 9-12 per cent CAGR between 2018-22 to US$ 26-30 billion, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

The Indian government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.

Exchange Rate Used: INR 1 = US$ 0.0155 as on March 30, 2018

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.

Industry

Browse:

Related News

Last Updated: July 03, 2018

Pharma Clusters
Industry Contacts

WINNING THE WORLD

Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between j...

Frye Womens Rachel TStrap Sandal Cement72573 2sK7J

India Now Magazine

The Luxe Edge - Reshaping India's Lifestyle Choices

English

Groove Women’s Talia Gladiator Sandal Cognac Black PRcuRR

Fintech, i.e. the technology that enables banking and financial services, is a very fast growing space in India, especially for the start-up domain. Fintechs are offering...

The Indian technology start-up domain is proudly placed at the fourth largest position in the world. The industry was sized at US$ 35 billion in FY18. Last decade saw eme...

Textiles have been one of the oldest and largest industries in India historically, second only to agriculture, and it generates jobs for millions of people. The current e...

Today is the most opportune time for India to revolutionise its science and technology ecosystem. The size of our economy provides the capital, manpower and market to inv...

Daimler India Commercial Vehicle has been able to create a space for its offerings in the already crowded domestic commercial vehicle market. Erich Nesselhauf, MD C...

TUV Rheinland India is a subsidiary of the TUV Rheinland Group, Germany. As part of the India, Middle East, Africa Asia Pacific Group, it caters to the Indian marke...

Netmed.com (India ki pharmacy), is an online portal for medicines where one can upload the prescription, order medicines, and get them delivered at the doorstep. The company came into being in 2015 and since then it is trying to make all the modern medicines available and affordable for all with a hybrid inventory/marketplace model...

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member? Login / Retrieve Password

Copyright © 2010-2018 India Brand Equity Foundation

This website uses cookies

URBANARA.co.uk uses cookies to improve your shopping experience. By continuing to use the site, you consent to our use of cookies.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Inactive cookies are cookies that are currently being classified, as well as cookies that have been deactivated, e.g. due to expired or paused marketing campaigns. These cookies are currently not in use.
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Cookie declaration last updated on 15/06/2018 by Absolute Footwear Womens Casual Sports/Fitness/Running/Outdoor Trainers/Shoes Black Sp98J9
Call us for free 0800 77 97 527 | LOGIN

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Odomolor Womens PU HighHeels RoundToe Solid Buckle PumpsShoes Beige 34 B6DFzB4t

Shop by Category

Shop by Collection

Last Chance: Living

Shop by Category

Shop by Collection

AllhqFashion Womens Solid Blend Materials HighHeels Open Toe Pullon Sandals Pink l0rKn
> Buying Guide > Polyester

Company

Sbicca Womens Hogan Heeled Sandal Tan Yzve4EqGki
Odomolor Womens PullOn SquareToe KittenHeels PU Solid PumpsShoes Beige xjRJM0Ql
Press
Birkis Tahiti Womens Sandals Red Rot Flower Pattern Red AdAcFSfE
Legal Disclaimer

Products

Blockchain
Buffalo Women’s 41502901 Cow Suede Ankle Boots Beige Taupe 01 AtZ41C
Paul Green Womens 4512172 Trainers White SgOlxe10i8
EMV Payment
Pleaser RADIANT708UV Clr/Neon H Pink 4rCgpGatG7
Smart Card Readers
Secure Crypto NFC modules
QuoVadis

Solutions

Chinese Laundry Women’s Ryden Heeled Sandal Nude Suede 5kCZSrJdn
RTRY WomenS Shoes Pu Fall Winter Comfort Novelty Fashion Boots Boots Wedge Heel Pointed Toe Booties/Ankle Boots Gore For Office amp;Amp; Career US55 / EU36 / UK35 / CN35 o4LdobNdpt
Secured IoT
Mobile Solutions
Wearable Payments
Secure Connected Cars

Investors

Comfylux Womens/Ladies Diana Floral Slippers Blue 5wSvo7
Corporate Calendar
Analyst Reports
Shareholders Contacts

WISeKey SA

Route de Pré-Bois 29, P.O. Box 853 CH-1215 Geneva 15, Switzerland Phone: +41 22 594 3000 Fax: +41 22 594 3001 General Information: info@wisekey.com Sales: sales@wisekey.com Technical Support: support@wisekey.com

Social

Copyright © 1999 - 2018 by WISeKey. All Rights Reserved. Repository | Legal disclaimer | Privacy | Terms and Conditions